What type of cluster randomized trial for which setting?


Journal

Journal of epidemiology and population health
ISSN: 2950-4333
Titre abrégé: J Epidemiol Popul Health
Pays: France
ID NLM: 9918769574106676

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 16 08 2023
revised: 03 01 2024
accepted: 08 01 2024
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: ppublish

Résumé

The cluster randomized trial allows a randomized evaluation when it is either not possible to randomize the individual or randomizing individuals would put the trial at high risk of contamination across treatment arms. There are many variations of the cluster randomized design, including the parallel design with or without baseline measures, the cluster randomized cross-over design, the stepped-wedge cluster randomized design, and more recently-developed variants such as the batched stepped-wedge design and the staircase design. Once it has been clearly established that there is a need for cluster randomization, one ever important question is which form the cluster design should take. If a design in which time is split into multiple trial periods is to be adopted (e.g. as in a stepped-wedge), researchers must decide whether the same participants should be measured in multiple trial periods (cohort sampling); or if different participants should be measured in each period (continual recruitment or cross-sectional sampling). Here we outline the different possible options and weigh up the pros and cons of the different design choices, which revolve around statistical efficiency, study logistics and the assumptions required.

Identifiants

pubmed: 38477476
pii: S2950-4333(24)00006-5
doi: 10.1016/j.jeph.2024.202195
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

202195

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare there is no conflict of interests.

Auteurs

Karla Hemming (K)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK. Electronic address: k.hemming@bham.ac.uk.

Andrew Copas (A)

MRC Clinical Trials Unit at University College London, London, UK.

Andrew Forbes (A)

School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.

Jessica Kasza (J)

School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.

Classifications MeSH